4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-009460
Chief Technology Officer sold 20,000 shares at an average $15.11 ($302,106)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-02-10 | Sale | −14,706 | $15.01 | $220,737 | 8,115,086 | D |
| Yan Ming Chief Technology Officer | 2022-02-10 | Sale | −5,294 | $15.37 | $81,369 | 8,109,792 | D |
| Open-market sales · 20,000 sh · avg $15.11 · $302,106 | |||||||
Loading xslF345X03/doc4.xml…